197 related articles for article (PubMed ID: 28471196)
21. A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma.
Davies AJ; Lee AM; Taylor C; Clear AJ; Goff LK; Iqbal S; Cuthbert-Heavens D; Calaminici M; Norton AJ; Lister TA; Fitzgibbon J
Leukemia; 2005 Aug; 19(8):1459-65. PubMed ID: 15902285
[TBL] [Abstract][Full Text] [Related]
22. Transformation of indolent follicular lymphoma into diffuse large B-cell lymphoma - the molecular basis of "cancer aggressiveness".
Kledus F; Filip D; Mráz M
Klin Onkol; 2023; 36(4):353-363. PubMed ID: 37877527
[TBL] [Abstract][Full Text] [Related]
23. The significance of FOXP1 in diffuse large B-cell lymphoma.
Gascoyne DM; Banham AH
Leuk Lymphoma; 2017 May; 58(5):1037-1051. PubMed ID: 27678023
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.
Roehle A; Hoefig KP; Repsilber D; Thorns C; Ziepert M; Wesche KO; Thiere M; Loeffler M; Klapper W; Pfreundschuh M; Matolcsy A; Bernd HW; Reiniger L; Merz H; Feller AC
Br J Haematol; 2008 Sep; 142(5):732-44. PubMed ID: 18537969
[TBL] [Abstract][Full Text] [Related]
25. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.
Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A
Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological prognostic indicators in 107 patients with diffuse large B-cell lymphoma transformed from follicular lymphoma.
Maeshima AM; Taniguchi H; Fukuhara S; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
Cancer Sci; 2013 Jul; 104(7):952-7. PubMed ID: 23521357
[TBL] [Abstract][Full Text] [Related]
27. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.
Devan J; Janikova A; Mraz M
Semin Oncol; 2018 Oct; 45(5-6):291-302. PubMed ID: 30360879
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma.
Bouska A; McKeithan TW; Deffenbacher KE; Lachel C; Wright GW; Iqbal J; Smith LM; Zhang W; Kucuk C; Rinaldi A; Bertoni F; Fitzgibbon J; Fu K; Weisenburger DD; Greiner TC; Dave BJ; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Delabie J; Jaffe ES; Braziel RM; Connors JM; Staudt LM; Chan WC
Blood; 2014 Mar; 123(11):1681-90. PubMed ID: 24037725
[TBL] [Abstract][Full Text] [Related]
29. The role of MYC in the transformation and aggressiveness of 'indolent' B-cell malignancies.
Filip D; Mraz M
Leuk Lymphoma; 2020 Mar; 61(3):510-524. PubMed ID: 31631728
[TBL] [Abstract][Full Text] [Related]
30. Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma.
Szereday Z; Csernus B; Nagy M; László T; Warnke RA; Matolcsy A
Am J Pathol; 2000 Mar; 156(3):1017-24. PubMed ID: 10702417
[TBL] [Abstract][Full Text] [Related]
31. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
Nyman H; Jerkeman M; Karjalainen-Lindsberg ML; Banham AH; Enblad G; Leppä S
Eur J Haematol; 2009 May; 82(5):364-72. PubMed ID: 19141121
[TBL] [Abstract][Full Text] [Related]
32. Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1.
Craig VJ; Cogliatti SB; Imig J; Renner C; Neuenschwander S; Rehrauer H; Schlapbach R; Dirnhofer S; Tzankov A; Müller A
Blood; 2011 Jun; 117(23):6227-36. PubMed ID: 21460242
[TBL] [Abstract][Full Text] [Related]
33. Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions.
Lossos IS; Levy R
Semin Cancer Biol; 2003 Jun; 13(3):191-202. PubMed ID: 12959350
[TBL] [Abstract][Full Text] [Related]
34. Current Methods of microRNA Analysis.
Bartošík M; Jiráková L
Klin Onkol; 2018; 31(Suppl 2):93-101. PubMed ID: 31023031
[TBL] [Abstract][Full Text] [Related]
35. Systematic analysis of the frequently amplified 2p15-p16.1 locus reveals PAPOLG as a potential proto-oncogene in follicular and transformed follicular lymphoma.
Kurşun D; Küçük C
Turk J Biol; 2019; 43():124-132. PubMed ID: 31410080
[TBL] [Abstract][Full Text] [Related]
36. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
37. Methylation changes of SIRT1, KLF4, DAPK1 and SPG20 in B-lymphocytes derived from follicular and diffuse large B-cell lymphoma.
Frazzi R; Zanetti E; Pistoni M; Tamagnini I; Valli R; Braglia L; Merli F
Leuk Res; 2017 Jun; 57():89-96. PubMed ID: 28324774
[TBL] [Abstract][Full Text] [Related]
38. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
[TBL] [Abstract][Full Text] [Related]
39. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.
Banham AH; Connors JM; Brown PJ; Cordell JL; Ott G; Sreenivasan G; Farinha P; Horsman DE; Gascoyne RD
Clin Cancer Res; 2005 Feb; 11(3):1065-72. PubMed ID: 15709173
[TBL] [Abstract][Full Text] [Related]
40. Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma.
Berglund M; Enblad G; Thunberg U; Amini RM; Sundström C; Roos G; Erlanson M; Rosenquist R; Larsson C; Lagercrantz S
Mod Pathol; 2007 Jan; 20(1):63-75. PubMed ID: 17170743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
